Ironwood Pharmaceuticals (IRWD) Invested Capital (2012 - 2026)

Ironwood Pharmaceuticals has disclosed Invested Capital across 15 years of filings, most recently posting $223.2 million for Q2 2026.

• In Q2 2026, Invested Capital fell 19.2% year-over-year to $223.2 million; the TTM figure through Jun 2026 stood at $223.2 million (down 19.2% YoY), while the FY2025 annual figure was $322.8 million, up 285.88% from the prior year.
• Invested Capital came in at $223.2 million for Q2 2026 at Ironwood Pharmaceuticals, down from $367.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $652.4 million in Q4 2022 to a low of $50.9 million in Q1 2025.
• Average Invested Capital over 5 years is $294.1 million, with a median of $252.3 million recorded in 2023.
• Year-over-year, Invested Capital tumbled 76.51% in 2023 and soared 621.75% in 2026.
• Over 5 years, Invested Capital stood at $652.4 million in 2022, then plunged by 76.51% to $153.3 million in 2023, then plunged by 45.41% to $83.7 million in 2024, then soared by 285.88% to $322.8 million in 2025, then sank by 30.88% to $223.2 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $223.2 million in Q2 2026, $367.7 million in Q1 2026, and $322.8 million in Q4 2025.